GR3005998T3 - - Google Patents

Info

Publication number
GR3005998T3
GR3005998T3 GR920402317T GR920402317T GR3005998T3 GR 3005998 T3 GR3005998 T3 GR 3005998T3 GR 920402317 T GR920402317 T GR 920402317T GR 920402317 T GR920402317 T GR 920402317T GR 3005998 T3 GR3005998 T3 GR 3005998T3
Authority
GR
Greece
Prior art keywords
diltiazem
nifedipine
verapamil
stroke
activity
Prior art date
Application number
GR920402317T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005998T3 publication Critical patent/GR3005998T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
GR920402317T 1986-01-10 1992-10-15 GR3005998T3 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/818,505 US4654372A (en) 1986-01-10 1986-01-10 Method for using verapamil for treating stroke

Publications (1)

Publication Number Publication Date
GR3005998T3 true GR3005998T3 (OSRAM) 1993-06-07

Family

ID=25225695

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402317T GR3005998T3 (OSRAM) 1986-01-10 1992-10-15

Country Status (8)

Country Link
US (1) US4654372A (OSRAM)
EP (1) EP0229644B1 (OSRAM)
JP (1) JPS62167725A (OSRAM)
AT (1) ATE81006T1 (OSRAM)
CA (1) CA1284950C (OSRAM)
DE (1) DE3781904T2 (OSRAM)
ES (1) ES2046178T3 (OSRAM)
GR (1) GR3005998T3 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
KR0133553B1 (ko) * 1989-06-16 1998-04-23 모리다 다까가즈 뇌기능 개선제
RU1804845C (ru) * 1991-02-15 1993-03-30 Институт Органического Синтеза Латвийской Ан Ноотропное вещество
US6083532A (en) 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
EP2322174B1 (en) * 1998-07-10 2015-09-23 Novartis Pharma AG Combined use of valsartan and calcium channel blockers for therapeutic purposes
WO2008031831A2 (en) * 2006-09-12 2008-03-20 Neurosearch A/S Pharmaceutical compositions comprising combinations of an ampa/kainate antagonistic compound and an inhibitor of a multidrug resistance protein
US20220125754A1 (en) * 2019-01-29 2022-04-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Treating the causative agent in adhesiogenesis
IL297333B2 (en) * 2020-04-17 2025-09-01 Honeybrains Llc Preparations and methods for treating neuropsychiatric disorders
WO2026002967A1 (en) 2024-06-24 2026-01-02 Universität Linz Leoligin and derivatives thereof as calcium channel blockers for the prevention and/or treatment of related diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568677A (en) * 1983-07-23 1986-02-04 Pfizer Inc. 2-(4-Pyrimidone alkoxyalkyl) dihydropyridine anti-ischaemic and antihypertensive agents
JPS60130517A (ja) * 1983-12-16 1985-07-12 Mitsui Pharmaceut Inc アレルギ−性鼻炎治療剤

Also Published As

Publication number Publication date
EP0229644A2 (en) 1987-07-22
EP0229644B1 (en) 1992-09-30
DE3781904D1 (de) 1992-11-05
ATE81006T1 (de) 1992-10-15
CA1284950C (en) 1991-06-18
JPS62167725A (ja) 1987-07-24
ES2046178T3 (es) 1995-04-01
EP0229644A3 (en) 1989-11-23
DE3781904T2 (de) 1993-02-25
US4654372A (en) 1987-03-31

Similar Documents

Publication Publication Date Title
OA08581A (en) Treatment of diseases caused by retroviruses.
ZA87219B (en) 4,5,6-substituted-n-(substituted-phenyl)-2-pyrimidinamines
NO167122C (no) Implanterbar kneprotese.
NO875487D0 (no) Fremgangsmaate for selektiv behandling av en undergrunnsformasjon.
NO872212D0 (no) Freseverktoey for trebearbeidning.
GR3005998T3 (OSRAM)
GR3004959T3 (OSRAM)
FI874166A7 (fi) 2',3'-dideoksisytidin-2'-eenin käyttö retroviruksilla infektoituneiden potilaiden hoitoon.
IT8619378A0 (it) Procedimento per omopolimerizzazione anionica di alfa-trifluorometilacrilato.
IT8820342A0 (it) Procedimento per la realizzazione di un corpo cavo.
ES2022208B3 (es) Agarre para un portaherramientas de una maquina-herramienta.
ES2113345T3 (es) Tratamiento de la disfuncion cardiaca con la ayuda de compuestos 15-ceto-prostaglandina.
IT8622149A0 (it) Procedimento per la produzione di gnocchi.
IT8619206A0 (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni.
RO95059A (ro) Procedeu pentru prepararea unor cicloalcancarboxanilide
IT1214310B (it) Procedimento per il trattamento continuo di tessuti, tessuti a maglia e simili.
IE902286L (en) Use of isoxazolin-3-one derivatives as antidepressants
IT1215960B (it) Procedimento per la carbocementazione di un pezzo di acciaio.
DE3467161D1 (de) Unsaturated arylalkyl ammonium salts
DE3681026D1 (de) Oxidierungsverfahren von 2,6-diisopropylnaphthalin.
FI871195A7 (fi) Menetelmä dihydro-1H-pyrrolitsiini-3,5 -(2H,6H)-dionien valmistamiseksi.
IL69101A0 (en) Nonapeptide having immunostimulative activity,process for the preparation thereof,and its use
IT8619935A0 (it) Procedimento per trattare maglieria.
IT8522409A0 (it) Procedimento per la produzione di2,3-diidro-2,2-dimetil-7-benzofuranolo.
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.